AVEO Pharmaceuticals Inc (AVEO)

6.64 +0.13  +2.00% NASDAQ Oct 20, 13:53 USD
View Full Chart
Price Chart
View All AVEO News

News

View All Events

Events

Date Type Description
05/10/2022 16:30 EST Earnings Calls Q1 2022 Earnings Call
11/09/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/09/2021 10:00 EST AGM 2021 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/16/2021 Earnings Results Q4 2020 Earnings Results
11/09/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: AVEO Pharmaceuticals Inc is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The company's aim is to retain North American rights to its oncology portfolio while securing partners in development and commercialization outside of North America. It is seeking to develop and commercialize its lead candidate tivozanib in North America as a treatment for advanced or metastatic renal cell carcinoma (RCC). It has out-licensed tivozanib (FOTIVDA) for oncology in Europe and other territories outside North America. Tivozanib is approved in the European Union as well as Norway and Iceland for the first-line treatment of adult patients with RCC.
  • URL: http://www.aveooncology.com
  • Investor Relations URL: http://investor.aveooncology.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 09, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.